2024-04-01 2025-09-30 false Capium Accounts Production 1.1 14744992 2024-04-01 2025-09-30 14744992 bus:AbridgedAccounts 2024-04-01 2025-09-30 14744992 bus:FRS102 2024-04-01 2025-09-30 14744992 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-09-30 14744992 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-09-30 14744992 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-09-30 14744992 2024-04-01 2025-09-30 14744992 2025-09-30 14744992 bus:RegisteredOffice 2024-04-01 2025-09-30 14744992 core:WithinOneYear 2025-09-30 14744992 core:AfterOneYear 2025-09-30 14744992 1 2024-04-01 2025-09-30 14744992 bus:Director1 2024-04-01 2025-09-30 14744992 bus:Director1 2025-09-30 14744992 bus:Director1 2023-03-21 2024-03-31 14744992 2023-03-21 14744992 bus:LeadAgentIfApplicable 2024-04-01 2025-09-30 14744992 2023-03-21 2024-03-31 14744992 2024-03-31 14744992 core:WithinOneYear 2024-03-31 14744992 core:AfterOneYear 2024-03-31 14744992 bus:EntityAccountantsOrAuditors 2023-03-21 2024-03-31 14744992 bus:OrdinaryShareClass1 2024-04-01 2025-09-30 14744992 bus:OrdinaryShareClass1 2025-09-30 14744992 bus:OrdinaryShareClass1 2023-03-21 2024-03-31 14744992 bus:OrdinaryShareClass1 2024-03-31 14744992 core:MotorCars 2024-04-01 2025-09-30 14744992 core:MotorCars 2025-09-30 14744992 core:MotorCars 2024-03-31 14744992 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-09-30 14744992 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 14744992 core:CostValuation core:Non-currentFinancialInstruments 2025-09-30 14744992 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 14744992 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-09-30 14744992 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 14744992 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 14744992 core:Non-currentFinancialInstruments 2025-09-30 14744992 core:Non-currentFinancialInstruments 2024-03-31 14744992 core:ShareCapital 2025-09-30 14744992 core:ShareCapital 2024-03-31 14744992 core:RetainedEarningsAccumulatedLosses 2025-09-30 14744992 core:RetainedEarningsAccumulatedLosses 2024-03-31 14744992 dpl:Item1 2024-04-01 14744992 dpl:Item1 2025-09-30 14744992 dpl:Item1 2023-03-21 14744992 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 14744992
England and Wales
VIMBAI HEALTH LTD
Abridged Accounts
Period of accounts Start date: 01 April 2024 End date: 30 September 2025

VIMBAI HEALTH LTD Contents Page For the Period 01 April 2024 to 30 September 2025
Statement of Financial Position | 1
Notes to the Financial Statements | 2

VIMBAI HEALTH LTD Statement of Financial Position As at 30 September 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 3 | 10,226 |  | 0
|  | 10,226 |  | 0
Current assets |  |  |
Debtors |  | 27,848 |  | 0
Cash at bank and in hand |  | 10,543 |  | 48,662
|  | 38,391 |  | 48,662
Creditors: amount falling due within one year |  | (17,224) |  | (20,808)
Net current assets |  | 21,167 |  | 27,854
Total assets less current liabilities |  | 31,393 |  | 27,854
Net assets |  | 31,393 |  | 27,854
Capital and reserves |  |  |
Called up share capital | 4 | 100 |  | 100
Profit and loss account |  | 31,293 |  | 27,754
Shareholders' funds |  | 31,393 |  | 27,854
For the period ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 23 April 2026 and were signed by:
------------------------------- Fortune MAGUNJE Director
1

VIMBAI HEALTH LTD Notes to the Abridged Financial Statements For the Period 01 April 2024 to 30 September 2025
General Information VIMBAI HEALTH LTD is a private company, limited by shares, registered in England and Wales, registration number 14744992, registration address 1 Chantry Road, Chessington, England, KT9 1JR. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Going concern basis The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Dividends Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
2. | Average number of employees Average number of employees during the period was 1 (2024 : 1).
3. | Tangible fixed assets
Cost or valuation | Motor Vehicles |  | Total
| £ |  | £
At 01 April 2024 | - |  | -
Additions | 10,550 |  | 10,550
Disposals | - |  | -
At 30 September 2025 | 10,550 |  | 10,550
Depreciation
At 01 April 2024 | - |  | -
Charge for period | 324 |  | 324
On disposals | - |  | -
At 30 September 2025 | 324 |  | 324
Net book values
Closing balance as at 30 September 2025 | 10,226 |  | 10,226
Opening balance as at 01 April 2024 | - |  | -
4. | Share Capital Authorised 100 Class A shares of £1.00 each
Allotted, called up and fully paid | 2025 £ |  | 2024 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
2